These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 8042445)
1. Recovery of the hypothalamic-pituitary-adrenal axis from suppression by short-term, high-dose intravenous prednisolone therapy in patients with MS. Wenning GK; Wiethölter H; Schnauder G; Müller PH; Kanduth S; Renn W Acta Neurol Scand; 1994 Apr; 89(4):270-3. PubMed ID: 8042445 [TBL] [Abstract][Full Text] [Related]
2. Recovery from glucocorticoid inhibition of the responses to corticotrophin-releasing hormone. Watson AC; Rosenfield RL; Fang VS Clin Endocrinol (Oxf); 1988 May; 28(5):471-7. PubMed ID: 2850875 [TBL] [Abstract][Full Text] [Related]
3. Recovery of responses to ovine corticotropin-releasing hormone after withdrawal of a short course of glucocorticoid. Brigell DF; Fang VS; Rosenfield RL J Clin Endocrinol Metab; 1992 May; 74(5):1036-9. PubMed ID: 1314844 [TBL] [Abstract][Full Text] [Related]
4. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease. Avgerinos PC; Nieman LK; Oldfield EH; Loughlin T; Barnes KM; Loriaux DL; Cutler GB J Clin Endocrinol Metab; 1989 May; 68(5):912-6. PubMed ID: 2541160 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of corticotropin releasing factor stimulation and basal markers of hypothalamic-pituitary-adrenal axis suppression in asthmatic patients. Clark DJ; Lipworth BJ Chest; 1997 Nov; 112(5):1248-52. PubMed ID: 9367464 [TBL] [Abstract][Full Text] [Related]
6. A Retrospective Study on Weaning Glucocorticoids and Recovery of the Hypothalamic-Pituitary-Adrenal Axis. Arshad MF; Elder C; Newell-Price J; Ross R; Debono M J Clin Endocrinol Metab; 2024 Oct; 109(11):e2031-e2037. PubMed ID: 38298131 [TBL] [Abstract][Full Text] [Related]
7. Short-term high dose steroid therapy does not affect the hypothalamic-pituitary-adrenal axis in relapsing multiple sclerosis patients. Clinical assessment by the insulin tolerance test. Lević Z; Micić D; Nikolić J; Stojisavljević N; Sokić D; Janković S; Kendereski A; Mavra M J Endocrinol Invest; 1996 Jan; 19(1):30-4. PubMed ID: 8851689 [TBL] [Abstract][Full Text] [Related]
8. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy. Cleare AJ; Miell J; Heap E; Sookdeo S; Young L; Malhi GS; O'Keane V J Clin Endocrinol Metab; 2001 Aug; 86(8):3545-54. PubMed ID: 11502777 [TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of hypothalamic-pituitary-adrenal system response to a combined dexamethasone-CRH test in multiple sclerosis. Grasser A; Möller A; Backmund H; Yassouridis A; Holsboer F Exp Clin Endocrinol Diabetes; 1996; 104(1):31-7. PubMed ID: 8750568 [TBL] [Abstract][Full Text] [Related]
11. Effects of different treatments for hyperthyroidism on the hypothalamic-pituitary-adrenal axis. Lizcano F; Salvador J Clin Exp Pharmacol Physiol; 2008 Sep; 35(9):1085-90. PubMed ID: 18505442 [TBL] [Abstract][Full Text] [Related]
12. Long-term treatment with corticosteroids/ACTH in asthmatic children. II. Hypothalamic-pituitary-adrenal function. Oberger E; Thorén M; Engström I Acta Paediatr Scand; 1986 Jan; 75(1):164-71. PubMed ID: 3006426 [TBL] [Abstract][Full Text] [Related]
13. Response of the hypothalamic-pituitary-adrenal axis to small dose arginine-vasopressin and daily urinary free cortisol before and after alprazolam pre-treatment differs in obesity. Vicennati V; Ceroni L; Gagliardi L; Pagotto U; Gambineri A; Genghini S; Pasquali R J Endocrinol Invest; 2004 Jun; 27(6):541-7. PubMed ID: 15717651 [TBL] [Abstract][Full Text] [Related]
14. Assessment of the hypothalamic-pituitary-adrenal axis function after corticosteroid therapy for MS relapses. Miró J; Amado JA; Pesquera C; López-Cordovilla JJ; Berciano J Acta Neurol Scand; 1990 Jun; 81(6):524-8. PubMed ID: 2171296 [TBL] [Abstract][Full Text] [Related]
15. A comparison of the naloxone test with ovine CRH and insulin hypoglycaemia in the evaluation of the hypothalamic-pituitary-adrenal axis in normal man. Inder WJ; Ellis MJ; Evans MJ; Donald RA Clin Endocrinol (Oxf); 1995 Oct; 43(4):425-31. PubMed ID: 7586616 [TBL] [Abstract][Full Text] [Related]
16. Suppression and recovery of the hypothalamic function after high-dose corticosteroid treatment in preterm infants. Ng PC; Lam CW; Lee CH; Chan IH; Wong SP; Fok TF Neonatology; 2008; 94(3):170-5. PubMed ID: 18612214 [TBL] [Abstract][Full Text] [Related]
17. Effect of acute and prolonged mineralocorticoid receptor blockade on spontaneous and stimulated hypothalamic-pituitary-adrenal axis in humans. Berardelli R; Karamouzis I; Marinazzo E; Prats E; Picu A; Giordano R; Ghigo E; Arvat E Eur J Endocrinol; 2010 Jun; 162(6):1067-74. PubMed ID: 20219855 [TBL] [Abstract][Full Text] [Related]
18. Comparison of methods for evaluation of the suppressive effects of prednisolone on the HPA axis and bone turnover: changes in s-DHEAS are as sensitive as the ACTH test. Gruvstad E; Hedner LP; Höglund P; Luts A; Norjavaara E Int J Clin Pharmacol Ther; 2014 Jan; 52(1):15-26. PubMed ID: 24120714 [TBL] [Abstract][Full Text] [Related]
19. Assessment of the hypothalamo-pituitary-adrenal axis in patients treated with radiotherapy and chemotherapy for childhood brain tumor. Schmiegelow M; Feldt-Rasmussen U; Rasmussen AK; Lange M; Poulsen HS; Müller J J Clin Endocrinol Metab; 2003 Jul; 88(7):3149-54. PubMed ID: 12843158 [TBL] [Abstract][Full Text] [Related]
20. Function of the hypothalamic-pituitary-adrenal axis in patients with fibromyalgia and low back pain. Griep EN; Boersma JW; Lentjes EG; Prins AP; van der Korst JK; de Kloet ER J Rheumatol; 1998 Jul; 25(7):1374-81. PubMed ID: 9676772 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]